<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00251862</url>
  </required_header>
  <id_info>
    <org_study_id>5R01HS013912-05</org_study_id>
    <nct_id>NCT00251862</nct_id>
  </id_info>
  <brief_title>Shared Decision-Making for Colorectal Cancer Screening</brief_title>
  <official_title>Shared Decision-Making for Colorectal Cancer Screening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Agency for Healthcare Research and Quality (AHRQ)</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Agency for Healthcare Research and Quality (AHRQ)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this study is to conduct a three-arm randomized controlled trial to
      evaluate the impact of an interactive, web-based decision aid on shared decision-making and
      patient adherence to colorectal cancer (CRC) screening recommendations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Colorectal cancer (CRC) is the second leading cause of cancer-related death and third most
      commonly diagnosed cancer among men and women in the United States. Screening has been shown
      to be a cost-effective strategy for reducing both CRC mortality through early detection and
      incidence through the detection and removal of precancerous adenomatous polyps (adenomas).
      Despite a compelling rationale and widespread endorsement by authoritative groups, screening
      rates remain far below those necessary to achieve significant reductions in CRC mortality or
      incidence. Poor patient acceptance and non-adherence to screening recommendations are partly
      responsible for low screening rates. Shared decision-making has been advocated as a
      potentially effective yet unproven strategy for addressing this problem. Implicit in this
      approach is the need for an unbiased decision aid that not only educates patients about the
      pros and cons of the different strategies so as to enable them to identify a preferred
      strategy but also empowers patients to take a proactive role in the decision-making process,
      thereby increasing satisfaction and promoting adherence. From a logistical standpoint, the
      decision aid must also be easy to implement in the ambulatory setting so as to maximize use
      but minimize demands on physician time and office resources. To address this need, we have
      developed an interactive, web-based decision aid and implementation strategy for use in
      routine clinical practice.

      Comparison(s): Average risk subjects assigned to one of two intervention arms (decision aid
      alone versus decision aid plus personalized risk assessment with feedback) compared to a
      control arm(generic website that discusses lifestyle changes that can reduce overall cancer
      risk).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Adherence (Test Completion)</measure>
    <time_frame>12 months post-intervention</time_frame>
    <description>Completion of a screening test within 12 months of the study visit.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Knowledge</measure>
    <time_frame>Immediate post-intervention study visit</time_frame>
    <description>Knowledge was assessed at baseline (pretest) and at the time of the exit survey (posttest) based on responses to a 12-item questionnaire (True/False/Don't know) that inquired about CRC risk factors, the rationale and goals of screening, and age at which screening should begin. Cumulative knowledge scores (range, 0-12) were derived by summing correct responses to the 12 individual knowledge questions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction With Decision Making Process</measure>
    <time_frame>Immediate post-intervention primary care provider (PCP) visit</time_frame>
    <description>Patient satisfaction with the decision-making process (SDMP) was assessed using the validated 12-item Satisfaction with the Decision-Making Process scale. Five ordered response categories were used for each item. Each response was assigned a point score ranging from 1 for &quot;strongly disagree&quot; (or &quot;poor&quot;) to 5 for &quot;strongly agree&quot; (or &quot;excellent&quot;). A cumulative score was calculated based on the summed response scores for each item (maximum score = 60). Mean item substitution was used to impute missing data.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Screening Intentions</measure>
    <time_frame>Immediate post-intervention study visit</time_frame>
    <description>Screening intentions were also assessed as part of the posttest. Subjects were asked how sure they were that they would schedule an appointment to get screened for colorectal cancer and how sure they were that they would complete the screening test they scheduled. An ordered 5-point response frame was used ranging from 1 for &quot;not at all sure&quot; to 5 for &quot;completely sure&quot;.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">825</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Decision aid plus YourDiseaseRisk</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients viewed the decision aid and completed the Your Disease Risk risk assessment tool prior to visit with their primary care provider.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Decision aid alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient's viewed decision aid only prior to a visit with their primary care provider.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>III</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Standard care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Web-based decision aid plus personalized risk assessment</intervention_name>
    <description>Patients review a computer-based decision aid that discuss the pros and cons of of 5 recommended CRC screening options and provides personalized 10-year estimates of CRC risk prior to meeting with their provider to discuss CRC screening.</description>
    <arm_group_label>Decision aid plus YourDiseaseRisk</arm_group_label>
    <other_name>Decision aid, personalized risk assessment tool</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Web-based decision aid alone</intervention_name>
    <description>Patients review a computer-based decision aid that discuss the pros and cons of the 5 recommended CRC screening options prior to meeting with their provider to discuss CRC screening.</description>
    <arm_group_label>Decision aid alone</arm_group_label>
    <other_name>Decision aid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Generic website</intervention_name>
    <description>Patients review a generic website that discuss ways to reduce overall cancer risk.</description>
    <arm_group_label>III</arm_group_label>
    <other_name>Control condtion</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Asymptomatic average-risk subjects

          -  Under the direct care of one of participating site's staff (attending) physicians or
             physician extenders;

          -  No prior screening other than fecal occult blood testing (FOBT);

          -  No major co-morbidities that preclude CRC screening by any method

        Exclusion Criteria:

          -  Prior CRC screening by any method other than FOBT occult blood testing

          -  High-risk condition (personal history of colorectal cancer or polyps, family history
             of colorectal cancer or polyps involving one or more first degree relatives, chronic
             inflammatory bowel disease)

          -  Lack of fluency in written and spoken English (since decision aid and personalized
             risk assessment tool will be in English only due to funding issues);

          -  Comorbidities that preclude CRC screening by any method
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul C. Schroy III, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Boston Community Health Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02127</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Schroy PC 3rd, Glick JT, Robinson PA, Lydotes MA, Evans SR, Emmons KM. Has the surge in media attention increased public awareness about colorectal cancer and screening? J Community Health. 2008 Feb;33(1):1-9.</citation>
    <PMID>18080203</PMID>
  </reference>
  <reference>
    <citation>Schroy PC 3rd, Glick JT, Robinson P, Lydotes MA, Heeren TC, Prout M, Davidson P, Wong JB. A cost-effectiveness analysis of subject recruitment strategies in the HIPAA era: results from a colorectal cancer screening adherence trial. Clin Trials. 2009 Dec;6(6):597-609. doi: 10.1177/1740774509346703. Epub 2009 Nov 23.</citation>
    <PMID>19933718</PMID>
  </reference>
  <reference>
    <citation>Schroy PC 3rd, Mylvaganam S, Davidson P. Provider perspectives on the utility of a colorectal cancer screening decision aid for facilitating shared decision making. Health Expect. 2014 Feb;17(1):27-35. doi: 10.1111/j.1369-7625.2011.00730.x. Epub 2011 Sep 8.</citation>
    <PMID>21902773</PMID>
  </reference>
  <results_reference>
    <citation>Schroy PC 3rd, Emmons K, Peters E, Glick JT, Robinson PA, Lydotes MA, Mylvanaman S, Evans S, Chaisson C, Pignone M, Prout M, Davidson P, Heeren TC. The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial. Med Decis Making. 2011 Jan-Feb;31(1):93-107. doi: 10.1177/0272989X10369007. Epub 2010 May 18.</citation>
    <PMID>20484090</PMID>
  </results_reference>
  <results_reference>
    <citation>Schroy PC 3rd, Emmons KM, Peters E, Glick JT, Robinson PA, Lydotes MA, Mylvaganam SR, Coe AM, Chen CA, Chaisson CE, Pignone MP, Prout MN, Davidson PK, Heeren TC. Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial. Am J Prev Med. 2012 Dec;43(6):573-83. doi: 10.1016/j.amepre.2012.08.018.</citation>
    <PMID>23159252</PMID>
  </results_reference>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2005</study_first_submitted>
  <study_first_submitted_qc>November 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2005</study_first_posted>
  <results_first_submitted>July 23, 2013</results_first_submitted>
  <results_first_submitted_qc>September 30, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 2, 2013</results_first_posted>
  <last_update_submitted>December 2, 2013</last_update_submitted>
  <last_update_submitted_qc>December 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 27, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colorectal cancer screening</keyword>
  <keyword>Shared decision-making</keyword>
  <keyword>Decision aid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>DA + YDR</title>
          <description>Decision aid (DA) plus Your Disease Risk (YDR) personalized risk feedback</description>
        </group>
        <group group_id="P2">
          <title>DA Alone</title>
          <description>Decision aid alone</description>
        </group>
        <group group_id="P3">
          <title>Control</title>
          <description>Standard Care</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="280"/>
                <participants group_id="P2" count="269"/>
                <participants group_id="P3" count="276"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="280"/>
                <participants group_id="P2" count="269"/>
                <participants group_id="P3" count="276"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>DA + YDR</title>
          <description>Decision aid (DA) plus Your Disease Risk (YDR) personalized risk feedback</description>
        </group>
        <group group_id="B2">
          <title>DA Alone</title>
          <description>Decision aid alone</description>
        </group>
        <group group_id="B3">
          <title>Control</title>
          <description>Standard Care</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="280"/>
            <count group_id="B2" value="269"/>
            <count group_id="B3" value="276"/>
            <count group_id="B4" value="825"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="232"/>
                    <measurement group_id="B2" value="234"/>
                    <measurement group_id="B3" value="230"/>
                    <measurement group_id="B4" value="696"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="46"/>
                    <measurement group_id="B4" value="129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="163"/>
                    <measurement group_id="B2" value="164"/>
                    <measurement group_id="B3" value="159"/>
                    <measurement group_id="B4" value="486"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="117"/>
                    <measurement group_id="B2" value="105"/>
                    <measurement group_id="B3" value="117"/>
                    <measurement group_id="B4" value="339"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="262"/>
                    <measurement group_id="B2" value="259"/>
                    <measurement group_id="B3" value="261"/>
                    <measurement group_id="B4" value="782"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="172"/>
                    <measurement group_id="B2" value="160"/>
                    <measurement group_id="B3" value="180"/>
                    <measurement group_id="B4" value="512"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="99"/>
                    <measurement group_id="B2" value="96"/>
                    <measurement group_id="B3" value="88"/>
                    <measurement group_id="B4" value="283"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="280"/>
                    <measurement group_id="B2" value="269"/>
                    <measurement group_id="B3" value="276"/>
                    <measurement group_id="B4" value="825"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Patient Adherence (Test Completion)</title>
        <description>Completion of a screening test within 12 months of the study visit.</description>
        <time_frame>12 months post-intervention</time_frame>
        <population>Intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>DA + YDR</title>
            <description>Decision aid (DA) plus Your Disease Risk (YDR) personalized risk feedback</description>
          </group>
          <group group_id="O2">
            <title>DA Alone</title>
            <description>Decision aid alone</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>Standard Care</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Adherence (Test Completion)</title>
          <description>Completion of a screening test within 12 months of the study visit.</description>
          <population>Intention to treat</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="280"/>
                <count group_id="O2" value="269"/>
                <count group_id="O3" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="104"/>
                    <measurement group_id="O2" value="116"/>
                    <measurement group_id="O3" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Sample size and power considerations focused on a two-group comparison of the DA alone versus control study arms for the primary outcome of colorectal cancer (CRC) screening test completion at 12 months. Based on crude estimates of baseline test completion rates, we calculated that a target sample of 275 subjects per arm provided greater than 80% power of detecting a 54% vs. 40% difference at the P&lt;0.05 level.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.046</p_value>
            <method>Chi-squared</method>
            <param_type>Absolute Difference</param_type>
            <param_value>8.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.2</ci_lower_limit>
            <ci_upper_limit>14.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.153</p_value>
            <method>Chi-squared</method>
            <param_type>Absolute Difference</param_type>
            <param_value>6.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.2</ci_lower_limit>
            <ci_upper_limit>16.5</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Knowledge</title>
        <description>Knowledge was assessed at baseline (pretest) and at the time of the exit survey (posttest) based on responses to a 12-item questionnaire (True/False/Don’t know) that inquired about CRC risk factors, the rationale and goals of screening, and age at which screening should begin. Cumulative knowledge scores (range, 0-12) were derived by summing correct responses to the 12 individual knowledge questions.</description>
        <time_frame>Immediate post-intervention study visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>DA + YDR</title>
            <description>Decision aid (DA) plus Your Disease Risk (YDR) personalized risk feedback</description>
          </group>
          <group group_id="O2">
            <title>DA Alone</title>
            <description>Decision aid alone</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>Standard Care</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Knowledge</title>
          <description>Knowledge was assessed at baseline (pretest) and at the time of the exit survey (posttest) based on responses to a 12-item questionnaire (True/False/Don’t know) that inquired about CRC risk factors, the rationale and goals of screening, and age at which screening should begin. Cumulative knowledge scores (range, 0-12) were derived by summing correct responses to the 12 individual knowledge questions.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="280"/>
                <count group_id="O2" value="269"/>
                <count group_id="O3" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.7" spread="1.9"/>
                    <measurement group_id="O2" value="10.9" spread="1.6"/>
                    <measurement group_id="O3" value="8.6" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The three study groups were compared on cumulative pre-test and post-test knowledge through separate one-factor analysis of covariance (ANCOVA); followed pairwise comparisons using Bonferroni’s adjusted multiple comparison procedure.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Pairwise comparisons: DA+YDR vs. Control, P&lt;0.001; DA alone vs. Control, P&lt;0.001</p_value_desc>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction With Decision Making Process</title>
        <description>Patient satisfaction with the decision-making process (SDMP) was assessed using the validated 12-item Satisfaction with the Decision-Making Process scale. Five ordered response categories were used for each item. Each response was assigned a point score ranging from 1 for “strongly disagree” (or “poor”) to 5 for “strongly agree” (or “excellent”). A cumulative score was calculated based on the summed response scores for each item (maximum score = 60). Mean item substitution was used to impute missing data.</description>
        <time_frame>Immediate post-intervention primary care provider (PCP) visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>DA + YDR</title>
            <description>Decision aid (DA) plus Your Disease Risk (YDR) personalized risk feedback</description>
          </group>
          <group group_id="O2">
            <title>DA Alone</title>
            <description>Decision aid alone</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>Standard Care</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction With Decision Making Process</title>
          <description>Patient satisfaction with the decision-making process (SDMP) was assessed using the validated 12-item Satisfaction with the Decision-Making Process scale. Five ordered response categories were used for each item. Each response was assigned a point score ranging from 1 for “strongly disagree” (or “poor”) to 5 for “strongly agree” (or “excellent”). A cumulative score was calculated based on the summed response scores for each item (maximum score = 60). Mean item substitution was used to impute missing data.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="280"/>
                <count group_id="O2" value="269"/>
                <count group_id="O3" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.0" spread="6.2"/>
                    <measurement group_id="O2" value="49.7" spread="6.4"/>
                    <measurement group_id="O3" value="45.5" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The three study groups were compared through separate one-factor analysis of covariance (ANCOVA); followed pairwise comparisons using Bonferroni’s adjusted multiple comparison procedure.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Screening Intentions</title>
        <description>Screening intentions were also assessed as part of the posttest. Subjects were asked how sure they were that they would schedule an appointment to get screened for colorectal cancer and how sure they were that they would complete the screening test they scheduled. An ordered 5-point response frame was used ranging from 1 for “not at all sure” to 5 for “completely sure”.</description>
        <time_frame>Immediate post-intervention study visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>DA + YDR</title>
            <description>Decision aid (DA) plus Your Disease Risk (YDR) personalized risk feedback</description>
          </group>
          <group group_id="O2">
            <title>DA Alone</title>
            <description>Decision aid alone</description>
          </group>
          <group group_id="O3">
            <title>Control</title>
            <description>Standard Care</description>
          </group>
        </group_list>
        <measure>
          <title>Screening Intentions</title>
          <description>Screening intentions were also assessed as part of the posttest. Subjects were asked how sure they were that they would schedule an appointment to get screened for colorectal cancer and how sure they were that they would complete the screening test they scheduled. An ordered 5-point response frame was used ranging from 1 for “not at all sure” to 5 for “completely sure”.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="280"/>
                <count group_id="O2" value="269"/>
                <count group_id="O3" value="276"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" spread="1.0"/>
                    <measurement group_id="O2" value="4.4" spread="1.0"/>
                    <measurement group_id="O3" value="4.0" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The three study groups were compared through separate one-factor analysis of covariance (ANCOVA); followed pairwise comparisons using Bonferroni’s adjusted multiple comparison procedure.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>DA + YDR</title>
          <description>Decision aid (DA) plus Your Disease Risk (YDR) personalized risk feedback</description>
        </group>
        <group group_id="E2">
          <title>DA Alone</title>
          <description>Decision aid alone</description>
        </group>
        <group group_id="E3">
          <title>Control</title>
          <description>Standard Care</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="280"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="269"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="276"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="280"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="269"/>
                <counts group_id="E3" subjects_affected="00" subjects_at_risk="276"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Paul C. Schroy III</name_or_title>
      <organization>Boston Medical Center</organization>
      <phone>617-638-8335</phone>
      <email>paul.schroy@bmc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

